• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性自身免疫疾病中细胞因子网络引发的骨质流失

Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.

作者信息

Amarasekara Dulshara Sachini, Yu Jiyeon, Rho Jaerang

机构信息

Department of Bioscience and Biotechnology, College of Biological Sciences and Biotechnology, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 305-764, Republic of Korea.

出版信息

J Immunol Res. 2015;2015:832127. doi: 10.1155/2015/832127. Epub 2015 May 4.

DOI:10.1155/2015/832127
PMID:26065006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4434203/
Abstract

Bone remodeling is a lifelong process in vertebrates that relies on the correct balance between bone resorption by osteoclasts and bone formation by osteoblasts. Bone loss and fracture risk are implicated in inflammatory autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, and systemic lupus erythematosus. The network of inflammatory cytokines produced during chronic inflammation induces an uncoupling of bone formation and resorption, resulting in significant bone loss in patients with inflammatory autoimmune diseases. Here, we review and discuss the involvement of the inflammatory cytokine network in the pathophysiological aspects and the therapeutic advances in inflammatory autoimmune diseases.

摘要

骨重塑是脊椎动物的一个终身过程,它依赖于破骨细胞的骨吸收和成骨细胞的骨形成之间的正确平衡。骨质流失和骨折风险与类风湿性关节炎、强直性脊柱炎、炎症性肠病和系统性红斑狼疮等炎症性自身免疫疾病有关。慢性炎症期间产生的炎症细胞因子网络会导致骨形成和吸收解偶联,从而导致炎症性自身免疫疾病患者出现显著的骨质流失。在此,我们综述并讨论炎症细胞因子网络在炎症性自身免疫疾病病理生理学方面的作用以及治疗进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51cd/4434203/06126cf39679/JIR2015-832127.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51cd/4434203/06126cf39679/JIR2015-832127.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51cd/4434203/06126cf39679/JIR2015-832127.001.jpg

相似文献

1
Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.炎症性自身免疫疾病中细胞因子网络引发的骨质流失
J Immunol Res. 2015;2015:832127. doi: 10.1155/2015/832127. Epub 2015 May 4.
2
Inflammation in bone physiology and pathology.骨生理学和病理学中的炎症。
Curr Opin Rheumatol. 2018 Jan;30(1):59-64. doi: 10.1097/BOR.0000000000000449.
3
Impact of inflammation on the osteoblast in rheumatic diseases.炎症对风湿性疾病成骨细胞的影响。
Curr Osteoporos Rep. 2014 Mar;12(1):9-16. doi: 10.1007/s11914-013-0183-y.
4
Mediators of inflammation and bone remodeling in rheumatic disease.风湿性疾病中炎症和骨重塑的介质
Semin Cell Dev Biol. 2016 Jan;49:2-10. doi: 10.1016/j.semcdb.2015.10.013. Epub 2015 Oct 19.
5
Bone remodeling in rheumatic disease: a question of balance.风湿性疾病中的骨重建:平衡问题。
Immunol Rev. 2010 Jan;233(1):301-12. doi: 10.1111/j.0105-2896.2009.00857.x.
6
Lymphocyte-derived cytokines in inflammatory arthritis.炎症性关节炎中淋巴细胞衍生的细胞因子
Autoimmunity. 2008 Apr;41(3):230-8. doi: 10.1080/08916930701694766.
7
[Osteoimmunology: how inflammation influences bone metabolism].[骨免疫学:炎症如何影响骨代谢]
Dtsch Med Wochenschr. 2013 Sep;138(37):1845-9. doi: 10.1055/s-0033-1349486. Epub 2013 Sep 4.
8
Inflammatory mediators and the destruction of bone.炎症介质与骨质破坏
J Periodontal Res. 1991 May;26(3 Pt 2):213-7. doi: 10.1111/j.1600-0765.1991.tb01647.x.
9
The role of stromal cells in inflammatory bone loss.基质细胞在炎性骨质流失中的作用。
Clin Exp Immunol. 2017 Jul;189(1):1-11. doi: 10.1111/cei.12979. Epub 2017 May 18.
10
The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling.白细胞介素-23 受体信号在炎症介导的侵蚀性自身免疫性关节炎和骨重塑中的作用。
Eur J Immunol. 2018 Feb;48(2):220-229. doi: 10.1002/eji.201646787. Epub 2018 Jan 15.

引用本文的文献

1
Bone Metabolism-related Serum Biomarkers and Nutritional Markers for Bone Fractures in Living-donor Kidney Transplant Recipients.活体肾移植受者骨折的骨代谢相关血清生物标志物和营养标志物
In Vivo. 2025 May-Jun;39(3):1492-1504. doi: 10.21873/invivo.13949.
2
Effects of chloroquine and hydroxychloroquine on bone health (Review).氯喹和羟氯喹对骨骼健康的影响(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13533. Epub 2025 Apr 17.
3
Progress in research on osteoporosis secondary to SARS-CoV-2 infection.新型冠状病毒肺炎继发骨质疏松症的研究进展

本文引用的文献

1
Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.联合抑制肿瘤坏死因子 α 和白细胞介素-17 作为类风湿关节炎的治疗机会:新型双特异性抗体的开发和表征。
Arthritis Rheumatol. 2015 Jan;67(1):51-62. doi: 10.1002/art.38896.
2
Bone marrow Th17 TNFα cells induce osteoclast differentiation, and link bone destruction to IBD.骨髓 Th17TNFα 细胞诱导破骨细胞分化,并将骨破坏与 IBD 联系起来。
Gut. 2015 Jul;64(7):1072-81. doi: 10.1136/gutjnl-2014-306947. Epub 2014 Oct 8.
3
Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.
Animal Model Exp Med. 2025 May;8(5):829-841. doi: 10.1002/ame2.12573. Epub 2025 Mar 3.
4
A child with Chronic Nonbacterial Osteomyelitis and celiac disease: accidental association or two different aspects of the same condition?一名患有慢性非细菌性骨髓炎和乳糜泻的儿童:偶然关联还是同一病症的两个不同方面?
Ital J Pediatr. 2025 Jan 30;51(1):22. doi: 10.1186/s13052-025-01842-x.
5
Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus.影响地诺单抗治疗系统性红斑狼疮骨质疏松症疗效的因素。
Lupus Sci Med. 2025 Jan 22;12(1):e001438. doi: 10.1136/lupus-2024-001438.
6
Functional hydrogel empowering 3D printing titanium alloys.功能水凝胶助力3D打印钛合金。
Mater Today Bio. 2024 Dec 24;30:101422. doi: 10.1016/j.mtbio.2024.101422. eCollection 2025 Feb.
7
mechanism of action in alveolar bone destruction: Scoping review.牙槽骨破坏的作用机制:范围综述
J Indian Soc Periodontol. 2024 May-Jun;28(3):290-296. doi: 10.4103/jisp.jisp_269_23. Epub 2024 Dec 2.
8
SARS-CoV-2 ORF8 drives osteoclastogenesis in preexisting immune-mediated inflammatory diseases.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的开放阅读框8(ORF8)在已有的免疫介导的炎症性疾病中驱动破骨细胞生成。
JCI Insight. 2024 Dec 20;9(24):e178820. doi: 10.1172/jci.insight.178820.
9
Targeting the osteoclastogenic cytokine IL-9 as a novel immunotherapeutic strategy in mitigating inflammatory bone loss in post-menopausal osteoporosis.将破骨细胞生成细胞因子白细胞介素-9作为一种新型免疫治疗策略,用于减轻绝经后骨质疏松症的炎症性骨质流失。
JBMR Plus. 2024 Sep 14;8(11):ziae120. doi: 10.1093/jbmrpl/ziae120. eCollection 2024 Nov.
10
Association between nonalcoholic fatty liver disease and bone mineral density: Mendelian randomization and mediation analysis.非酒精性脂肪性肝病与骨密度之间的关联:孟德尔随机化和中介分析
Bone Rep. 2024 Jun 26;22:101785. doi: 10.1016/j.bonr.2024.101785. eCollection 2024 Sep.
在炎症性肠病患者中,Th17细胞及Th17相关细胞因子水平升高与疾病活动相关。
Inflamm Res. 2014 Nov;63(11):943-50. doi: 10.1007/s00011-014-0768-7. Epub 2014 Aug 18.
4
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.IL-17 和 Th17 细胞在系统性红斑狼疮中的新作用。
Clin Immunol. 2014 Sep;154(1):1-12. doi: 10.1016/j.clim.2014.05.004. Epub 2014 May 23.
5
Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease.丹麦炎症性肠病患者中NFκB信号通路功能多态性与抗TNF治疗反应之间的关联。
Pharmacogenomics J. 2014 Dec;14(6):526-34. doi: 10.1038/tpj.2014.19. Epub 2014 Apr 29.
6
T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?辅助性T细胞17细胞细胞因子与I型干扰素:系统性红斑狼疮中的共犯?
Arthritis Res Ther. 2014 Mar 6;16(2):R62. doi: 10.1186/ar4499.
7
Classical and Paradoxical Effects of TNF-α on Bone Homeostasis.肿瘤坏死因子-α对骨稳态的经典及矛盾效应
Front Immunol. 2014 Feb 13;5:48. doi: 10.3389/fimmu.2014.00048. eCollection 2014.
8
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN).托珠单抗治疗强直性脊柱炎:一项II期随机双盲安慰剂对照研究(ALIGN)的结果
Ann Rheum Dis. 2015 Jun;74(6):1051-7. doi: 10.1136/annrheumdis-2013-204963. Epub 2014 Feb 18.
9
Immunopathology of inflammatory bowel disease.炎症性肠病的免疫病理学。
World J Gastroenterol. 2014 Jan 7;20(1):6-21. doi: 10.3748/wjg.v20.i1.6.
10
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.白细胞介素-6受体抑制剂托珠单抗对类风湿关节炎患者关节破坏的预防作用,这些患者对肿瘤坏死因子抑制剂反应不足。
Mod Rheumatol. 2014 May;24(3):399-404. doi: 10.3109/14397595.2013.843757. Epub 2013 Nov 5.